Literature DB >> 33431073

Development of a probability calculator for psychosis risk in children, adolescents, and young adults.

Tyler M Moore1,2, Monica E Calkins1,2, Adon F G Rosen1, Ellyn R Butler1, Kosha Ruparel1,2, Paolo Fusar-Poli3,4,5, Nikolaos Koutsouleris6, Philip McGuire3, Tyrone D Cannon7, Ruben C Gur1,2, Raquel E Gur1,2.   

Abstract

BACKGROUND: Assessment of risks of illnesses has been an important part of medicine for decades. We now have hundreds of 'risk calculators' for illnesses, including brain disorders, and these calculators are continually improving as more diverse measures are collected on larger samples.
METHODS: We first replicated an existing psychosis risk calculator and then used our own sample to develop a similar calculator for use in recruiting 'psychosis risk' enriched community samples. We assessed 632 participants age 8-21 (52% female; 48% Black) from a community sample with longitudinal data on neurocognitive, clinical, medical, and environmental variables. We used this information to predict psychosis spectrum (PS) status in the future. We selected variables based on lasso, random forest, and statistical inference relief; and predicted future PS using ridge regression, random forest, and support vector machines.
RESULTS: Cross-validated prediction diagnostics were obtained by building and testing models in randomly selected sub-samples of the data, resulting in a distribution of the diagnostics; we report the mean. The strongest predictors of later PS status were the Children's Global Assessment Scale; delusions of predicting the future or having one's thoughts/actions controlled; and the percent married in one's neighborhood. Random forest followed by ridge regression was most accurate, with a cross-validated area under the curve (AUC) of 0.67. Adjustment of the model including only six variables reached an AUC of 0.70.
CONCLUSIONS: Results support the potential application of risk calculators for screening and identification of at-risk community youth in prospective investigations of developmental trajectories of the PS.

Entities:  

Keywords:  Feature-selection; prodrome; psychosis spectrum; recruiting; risk calculator

Year:  2021        PMID: 33431073      PMCID: PMC8273212          DOI: 10.1017/S0033291720005231

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   10.592


  53 in total

1.  Risk factors for psychosis: impaired social and role functioning.

Authors:  Barbara A Cornblatt; Ricardo E Carrión; Jean Addington; Larry Seidman; Elaine F Walker; Tyronne D Cannon; Kristin S Cadenhead; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Scott W Woods; Robert Heinssen; Todd Lencz
Journal:  Schizophr Bull       Date:  2011-11-10       Impact factor: 9.306

2.  Using Lasso for Predictor Selection and to Assuage Overfitting: A Method Long Overlooked in Behavioral Sciences.

Authors:  Daniel M McNeish
Journal:  Multivariate Behav Res       Date:  2015       Impact factor: 5.923

3.  Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data.

Authors:  J Kaufman; B Birmaher; D Brent; U Rao; C Flynn; P Moreci; D Williamson; N Ryan
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-07       Impact factor: 8.829

Review 4.  Prediction of conversion to psychosis in individuals with an at-risk mental state: a brief update on recent developments.

Authors:  Anita Riecher-Rössler; Erich Studerus
Journal:  Curr Opin Psychiatry       Date:  2017-05       Impact factor: 4.741

5.  Validating the Predictive Accuracy of the NAPLS-2 Psychosis Risk Calculator in a Clinical High-Risk Sample From the SHARP (Shanghai At Risk for Psychosis) Program.

Authors:  TianHong Zhang; HuiJun Li; YingYing Tang; Margaret A Niznikiewicz; Martha E Shenton; Matcheri S Keshavan; William S Stone; Robert W McCarley; Larry J Seidman; JiJun Wang
Journal:  Am J Psychiatry       Date:  2018-09-01       Impact factor: 18.112

6.  Psychometric properties of the Penn Computerized Neurocognitive Battery.

Authors:  Tyler M Moore; Steven P Reise; Raquel E Gur; Hakon Hakonarson; Ruben C Gur
Journal:  Neuropsychology       Date:  2014-09-01       Impact factor: 3.295

7.  Computerized neurocognitive scanning: I. Methodology and validation in healthy people.

Authors:  R C Gur; J D Ragland; P J Moberg; T H Turner; W B Bilker; C Kohler; S J Siegel; R E Gur
Journal:  Neuropsychopharmacology       Date:  2001-11       Impact factor: 7.853

8.  Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons.

Authors:  Karl Y Bilimoria; Yaoming Liu; Jennifer L Paruch; Lynn Zhou; Thomas E Kmiecik; Clifford Y Ko; Mark E Cohen
Journal:  J Am Coll Surg       Date:  2013-09-18       Impact factor: 6.113

9.  What causes psychosis? An umbrella review of risk and protective factors.

Authors:  Joaquim Radua; Valentina Ramella-Cravaro; John P A Ioannidis; Abraham Reichenberg; Nacharin Phiphopthatsanee; Taha Amir; Hyi Yenn Thoo; Dominic Oliver; Cathy Davies; Craig Morgan; Philip McGuire; Robin M Murray; Paolo Fusar-Poli
Journal:  World Psychiatry       Date:  2018-02       Impact factor: 49.548

10.  A cognitive neuroscience-based computerized battery for efficient measurement of individual differences: standardization and initial construct validation.

Authors:  Ruben C Gur; Jan Richard; Paul Hughett; Monica E Calkins; Larry Macy; Warren B Bilker; Colleen Brensinger; Raquel E Gur
Journal:  J Neurosci Methods       Date:  2009-11-27       Impact factor: 2.390

View more
  2 in total

1.  Issues in Estimating Interpretable Lower Order Factors in Second-Order Hierarchical Models: Commentary on Clark et al. (2021).

Authors:  Tyler M Moore; Benjamin B Lahey
Journal:  Clin Psychol Sci       Date:  2021-08-09

2.  Clinical Consequences of Motor Behavior as Transdiagnostic Phenomenon.

Authors:  Peter N Van Harten; Lydia E Pieters
Journal:  Schizophr Bull       Date:  2022-06-21       Impact factor: 7.348

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.